Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Avacta has entered into a collaboration with Adeptrix to develop a high throughput COVID-19 antigen test using Adeptrix’s proprietary BAMS™ platform.
read more
Catalent announced the appointment of Manja Boerman, Ph.D., to the role of President, Cell & Gene Therapy, effective June 1, 2020.
read more
Ajinomoto Bio-Pharma Services has entered into a manufacturing services agreement with CytoDyn for the supply of the investigational new drug, leronlimab.
read more
Aravive and WuXi Biologics announced a strategic collaboration agreement granting Aravive the right to use the proprietary WuXiBody™ platform to develop high-affinity bispecific antibodies for a target implicated in cancer and fibrosis.
read more
Trio Pharmaceuticals and Ajinomoto Bio-Pharma Services announced a development collaboration agreement to evaluate AJICAP.
read more
Catalent’s Biologics business unit will accelerate availability of manufacturing capacity and prepare for large-scale commercial manufacturing of Johnson & Johnson’s lead vaccine candidate for COVID-19.
read more
INOVIO has entered into an agreement to expand its manufacturing partnership with the German contract manufacturer Richter-Helm BioLogics GmbH & Co. KG, to support large-scale manufacturing of INOVIO's investigational DNA vaccine INO-4800.
read more
CrO Biosciences announced Laura A. Jones as President. Jones will focus on leading global regulatory strategic development, oversight of regulatory operations, clinical operations and R&D systems implementation strategies.
read more
MediWound announced the expansion of its NexoBrid® European presence with distribution agreements with GENFA MEDICA and Specialty Therapeutics.
read more
Panthera is now undertaking Phase II, III and IV vaccine trials on behalf of its pharma and CRO clients across its growing network of sites in the UK.
read more
Hovione announced the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020.
read more
The Wasdell Group has announced a multi-million-pound investment in new packaging equipment across its sites in the UK and Ireland.
read more
AMRI has announced its ongoing commitment to do its part in support of public health needs amidst the COVID-19 pandemic.
read more
Arcturus and Catalent have announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate intended to protect against the SARS-CoV-2 coronavirus.
read more
Adare Pharmaceuticals has acquired pharmaceutical technology company, Orbis Biosciences.
read more